CompletedNot Applicable

Registry of Food Allergy Oral Immunotherapy Treatment

United States2,000 participantsStarted 2017-04-15

Plain-language summary

The purpose of this patient registry is to demonstrate safety and efficacy of food oral immunotherapy in food allergic patients. Factors that lead to adverse reactions will be identified. The frequency of rescue epinephrine use will be recorded.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * a history of an allergic reaction following exposure to the food and positive in-vivo or in-vitro sensitivity testing to the food, * no prior exposure to the food, but markedly high in-vitro specific immunoglobulin E (IgE) to the food Exclusion Criteria: * pregnancy * severe asthma * poorly controlled atopic dermatitis * eosinophilic esophagitis

What they're measuring

efficacy of food allergy treatment

Timeframe: 3 years

Trial details

NCT IDNCT03059589

SponsorFood Allergy Support Team

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-08-20

View on ClinicalTrials.gov More Food Allergy trials